China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Therapeutic Effects of Conbercept on Cuproptosis in Diabetic Retinopathy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129904
Registration Time: 2026/08/11
Type: Observational study
Primary Sponsor: The Second Affiliated Hospital of Harbin Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=328962
Published by HT Digital Content Services with permission from Health Daily Digest....